Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Farmers Insurance
Fuji
Harvard Business School
Dow
Boehringer Ingelheim
Covington
Cerilliant
QuintilesIMS

Generated: November 14, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020579

« Back to Dashboard

NDA 020579 describes FLOMAX, which is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. Additional details are available on the FLOMAX profile page.

The generic ingredient in FLOMAX is tamsulosin hydrochloride. There are thirty-three drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the tamsulosin hydrochloride profile page.
Summary for 020579
Tradename:FLOMAX
Applicant:Boehringer Ingelheim
Ingredient:tamsulosin hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020579
Mechanism of ActionAdrenergic alpha-Antagonists
Suppliers and Packaging for NDA: 020579
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0058 0597-0058-01 100 CAPSULE in 1 BOTTLE (0597-0058-01)
FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579 NDA Bryant Ranch Prepack 63629-3384 63629-3384-1 30 CAPSULE in 1 BOTTLE (63629-3384-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength0.4MG
Approval Date:Apr 15, 1997TE:ABRLD:Yes

Expired US Patents for NDA 020579

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Cantor Fitzgerald
Medtronic
US Army
McKesson
Healthtrust
Mallinckrodt
Farmers Insurance
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.